Funder
Japan Agency for Medical Research and Development
Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Genetics
Reference48 articles.
1. Pharmaceuticals and Medical Devices Agency—Drug label. 2019.
https://www.pmda.go.jp/PmdaSearch/iyakuDetail/ResultDataSetPDF/800015_4240404A1040_1_11
.
2. Food and Drug Administration—Drug label. 2014.
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020571s048lbl.pdf
.
3. Hikino K, Fukunaga K, Mushiroda T. Gap between the US and Japan in coverage of pharmacogenomic biomarkers by health insurance programs: more coverage is needed in Japan. Drug Metab Pharmacokinet. 2018;33:243–9.
4. Zhang X, Yin JF, Zhang J, Kong SJ, Zhang HY, Chen XM. UGT1A1*6 polymorphisms are correlated with irinotecan-induced neutropenia: a systematic review and meta-analysis. Cancer Chemother Pharmacol. 2017;80:135–49.
5. Chen YJ, Hu F, Li CY, Fang JM, Chu L, Zhang X, et al. The association of UGT1A1*6 and UGT1A1*28 with irinotecan-induced neutropenia in Asians: a meta-analysis. Biomarkers. 2014;19:56–62.
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献